COURT-RULING ·Filed Sep 28, 2026
Court ruling (district)
Actionable Insight • Neutral
This filing is administrative and has no trading implications. Monitor the docket for substantive rulings (e.g., summary judgment, trial date) in the underlying antitrust/contract case.
Latest settled — T+5d ⚠ clustered
MRK ▼ -4.92% at T+5d
NEUTRAL call -4.92% · α vs SPY -6.87% · entry $149.28 → $141.94
Latest observation: T+18 -10.04% FF3 residual α
T+1d
-2.66%
call -2.66% · α -2.45%
$145.31
settled 27d ago
T+5d
-4.92%
call -4.92% · α -6.87%
$141.94
settled 21d ago
T+20d
Pending
in 11h
T+60d
Pending
in 8w
Price Chart
Loading chart...
Executive Summary
This is a routine procedural order granting pro hac vice admission for an attorney in the ongoing Kaiser Foundation Health Plan v. Merck litigation. The order has no substantive impact on the merits of the case or Merck's financial exposure.
Court Ruling Details
Ruling Date
Sep 28, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Case Type
other
Ruling Type
other
Precedent Risk
LOW
Key Facts
- Order grants pro hac vice admission for attorney Amy Pauli to represent plaintiff Kaiser Foundation Health Plan in the Northern District of California.
- The underlying case is Kaiser Foundation Health Plan Inc v. Merck & Company Inc. et al (Case No. 4:21-cv-05497-HSG).
- No substantive ruling on the merits, damages, or injunctive relief was issued.
Financial Impact
No financial impact — the order is purely procedural and does not address liability, damages, or business operations.
Risk Factors
- The underlying Kaiser litigation could still result in material financial exposure if Merck loses on the merits, but this order does not change that risk profile.
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-3716b3c2ac-MRK |
28 reports for MRK
75% Hit rate @ T+20 Went positive at some point 4 of 6 best @ T+20▲ +16.92%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 3/A | $145.27 | awaiting T+20 | — | $145.27 (+0.00%) |
Oct 21, 2026 6d ago | PTAB Trial | $147.24 | awaiting T+20 | — | $145.27 (−1.34%) |
Oct 15, 2026 12d ago | PTAB Trial | $145.95 | awaiting T+20 | — | $145.27 (−0.47%) |
Oct 15, 2026 12d ago | PTAB Trial | $145.95 | awaiting T+20 | — | $145.27 (−0.47%) |
Oct 13, 2026 13d ago | 8-K | $141.98 | awaiting T+20 | — | $145.27 (+2.32%) |
Sep 29, 2026 28d ago | Court Ruling | $145.31 | awaiting T+20 | — | $145.27 (−0.03%) |
Sep 28, 2026 29d ago | Court Ruling | $149.28 | awaiting T+20 | — | $145.27 (−2.69%) |
Sep 22, 2026 5w ago | Court Ruling | $148.08 $149.88 | ▲ +1.22% | ▲ +0.53% | $145.27 (−1.90%) |
Sep 11, 2026 6w ago | Court Ruling | $144.85 $145.45 | ▲ +0.41% | ▼ −1.85% | $145.27 (+0.29%) |
Sep 9, 2026 6w ago | Court Ruling | $144.71 $142.38 | ▼ −1.61% | ▼ −3.73% | $145.27 (+0.39%) |
Showing 10 of 28
US Market Status
Market Closed — Opens Wed (12h 15m)
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers